| Is radiotherapy useful for treating pain in mesothelioma?: a phase II trial N MacLeod, A Chalmers, N O’Rourke, K Moore, J Sheridan, L McMahon, ... Journal of Thoracic Oncology 10 (6), 944-950, 2015 | 100 | 2015 |
| Clinical management of pain in advanced lung cancer CPL Simmons, N MacLeod, BJA Laird Clinical Medicine Insights: Oncology 6, CMO. S8360, 2012 | 96 | 2012 |
| Influence of high altitude on cerebral blood flow and fuel utilization during exercise and recovery KJ Smith, D MacLeod, CK Willie, NCS Lewis, RL Hoiland, K Ikeda, ... The Journal of physiology 592 (24), 5507-5527, 2014 | 94 | 2014 |
| Angiotensin-converting enzyme genotype and the ventilatory responseto exertional hypoxia S Patel, DR Woods, NJ Macleod, A Brown, KR Patel, HE Montgomery, ... European Respiratory Journal 22 (5), 755-760, 2003 | 79 | 2003 |
| Radiotherapy for the treatment of pain in malignant pleural mesothelioma: a systematic review N Macleod, A Price, N O’rourke, M Fallon, B Laird Lung Cancer 83 (2), 133-138, 2014 | 59 | 2014 |
| Effect of small angiokinase inhibitor nintedanib (BIBF 1120) on QT interval in patients with previously untreated, advanced renal cell cancer in an open-label, phase II study T Eisen, Y Shparyk, N Macleod, R Jones, G Wallenstein, G Temple, ... Investigational new drugs 31, 1283-1293, 2013 | 57 | 2013 |
| A randomised, phase II study of nintedanib or sunitinib in previously untreated patients with advanced renal cell cancer: 3-year results T Eisen, AB Loembe, Y Shparyk, N MacLeod, RJ Jones, M Mazurkiewicz, ... British Journal of Cancer 113 (8), 1140-1147, 2015 | 39 | 2015 |
| Sea level and acute responses to hypoxia: do they predict physiological responses and acute mountain sickness at altitude? S Grant, N MacLeod, JW Kay, M Watt, S Patel, A Paterson, A Peacock British Journal of Sports Medicine 36 (2), 141-146, 2002 | 35 | 2002 |
| Phase II efficacy and safety study of nintedanib versus sunitinib in previously untreated renal cell carcinoma (RCC) patients. T Eisen, Y Shparyk, R Jones, NJ MacLeod, G Temple, H Finnigan, ... Journal of Clinical Oncology 31 (15_suppl), 4506-4506, 2013 | 27 | 2013 |
| The relationship between 18F-FDG-PETCT-derived tumour metabolic activity, nutritional risk, body composition, systemic inflammation and survival in patients with … RD Dolan, JD Maclay, T Abbass, D Colville, F Buali, N MacLeod, ... Scientific Reports 10 (1), 20819, 2020 | 25 | 2020 |
| Real‐world uptake, safety profile and outcomes of docetaxel in newly diagnosed metastatic prostate cancer RJ Rulach, S McKay, S Neilson, L White, J Wallace, R Carruthers, ... BJU international 121 (2), 268-274, 2018 | 23 | 2018 |
| SYSTEMS-2: a randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma M Ashton, N O'Rourke, N Macleod, B Laird, J Stobo, C Kelly, L Alexander, ... Clinical and translational radiation oncology 8, 45-49, 2018 | 22 | 2018 |
| Pain management in patients with malignant mesothelioma: challenges and solutions J Saunders, M Ashton, C Hall, B Laird, N MacLeod Lung Cancer: Targets and Therapy, 37-46, 2019 | 18 | 2019 |
| Cardiac structure and function in adolescent Sherpa; effect of habitual altitude and developmental stage M Stembridge, PN Ainslie, J Donnelly, NT MacLeod, S Joshi, MG Hughes, ... American Journal of Physiology-Heart and Circulatory Physiology 310 (6 …, 2016 | 18 | 2016 |
| Pain in malignant pleural mesothelioma: a prospective characterization study N MacLeod, C Kelly, J Stobo, L McMahon, D Taggart, M Fallon, BJ Laird Pain Medicine 17 (11), 2119-2126, 2016 | 17 | 2016 |
| Comparison of the prognostic value of MUST, ECOG-PS, mGPS and CT derived body composition analysis in patients with advanced lung cancer T Abbass, RD Dolan, N MacLeod, PG Horgan, BJ Laird, DC McMillan Clinical nutrition ESPEN 40, 349-356, 2020 | 16 | 2020 |
| Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy L Devlin, D Dodds, A Sadozye, P McLoone, N MacLeod, C Lamb, ... The British journal of radiology 93 (1108), 20190789, 2020 | 11 | 2020 |
| An innovative family medicine clerkship. SR Smith, NM MacLeod The Journal of Family Practice 13 (5), 687-692, 1981 | 10 | 1981 |
| Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in … CC Parker, H Kynaston, AD Cook, NW Clarke, CN Catton, WR Cross, ... The Lancet 403 (10442), 2416-2425, 2024 | 9 | 2024 |
| Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the … CC Parker, NW Clarke, AD Cook, H Kynaston, CN Catton, WR Cross, ... The Lancet 403 (10442), 2405-2415, 2024 | 9 | 2024 |
